ProQR Therapeutics Company
A biotechnology company dedicated to changing lives by developing RNA therapies for rare genetic diseases. ProQR Therapeutics focuses their drug development mainly on a group of blinding disorders affecting the retina, called inherited retinal diseases.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
The Netherlands
Register and Claim Ownership